ibrutinib
janssen,abbvie
['ibru', 'congrat', 'cll']
congratulations to our star fellow from for presenting the updated follow-up of our ibrut + obin ist for r/r cll here in vienna! 
Hematologist/oncologist, CLL researcher, director of #lymphoma clinical research @DanaFarber, faculty @harvardmed. Tweets are my own & not medical advice.